Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RBM20 variants disrupt Ca<sup>2+</sup> handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.

Signal transduction and targeted therapy·2026
Same author

QutRNA2: robust tRNA modification discovery from Nanopore direct tRNA sequencing.

NAR genomics and bioinformatics·2026
Same author

Towards the construction of a virtual yeast.

Nature·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Desmoglein-2 deficiency drives mitochondrial morphological remodeling in cardiomyocytes.

American journal of physiology. Heart and circulatory physiology·2026
Same author

SIRT2 antagonizes MOF function during mitotic entry.

Science advances·2026

Related Experiment Video

Updated: May 6, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.7K

CAMK2D causes heart failure in mice with RBM20 cardiomyopathy.

Maarten M G van den Hoogenhof1,2,3,4, Javier Duran5,6,7,8, Thiago Britto-Borges7,9

  • 1Heidelberg University, Medical Faculty Heidelberg, Institute of Experimental Cardiology, Heidelberg, Germany. maarten.hoogenhof@cardioscience.uni-heidelberg.de.

Nature Cardiovascular Research
|May 4, 2026
PubMed
Summary

RBM20 gene variants cause dilated cardiomyopathy by overactivating CAMK2D signaling. Inhibiting CAMK2D offers a targeted therapy for this aggressive heart disease, improving cardiac function and survival.

More Related Videos

Ambulatory ECG Recording in Mice
08:00

Ambulatory ECG Recording in Mice

Published on: May 27, 2010

23.9K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

2.0K

Related Experiment Videos

Last Updated: May 6, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.7K
Ambulatory ECG Recording in Mice
08:00

Ambulatory ECG Recording in Mice

Published on: May 27, 2010

23.9K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

2.0K

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetic Heart Disease

Background:

  • Heart disease treatments are often generalized, necessitating cause-directed therapies.
  • Pathogenic variants in the RBM20 gene cause aggressive dilated cardiomyopathy and increase arrhythmia risk.

Purpose of the Study:

  • To investigate the role of calcium/calmodulin-dependent kinase II delta (CAMK2D) as a disease-causing factor in RBM20 cardiomyopathy.
  • To explore CAMK2D inhibition as a potential cause-directed therapy.

Main Methods:

  • Generated and analyzed Rbm20/Camk2d double knockout mice.
  • Assessed cardiac function and signaling pathways in mouse models.
  • Evaluated the therapeutic effect of the CAMK2 inhibitor hesperadin in RBM20 cardiomyopathy models.

Main Results:

  • Rbm20/Camk2d double knockout mice were protected from heart failure and sudden cardiac death.
  • RBM20 deficiency led to increased phosphorylation of CAMK2D targets, indicating functional CAMK2D overactivation.
  • Reintroducing CAMK2D splice variants caused cardiac dysfunction, confirming overactivation drives disease.
  • Hesperadin treatment improved cardiac function in RBM20 cardiomyopathy mice.

Conclusions:

  • CAMK2D overactivation is a central mechanism in RBM20-related cardiomyopathy.
  • Targeted inhibition of CAMK2D represents a promising therapeutic strategy for RBM20 cardiomyopathy.